Bavarian Biotech Report 2011/2012 (7MB) - Bio M

Syntacoll GmbHPHARMA & CHEMICAL INDUSTRYSyntacoll is the manufacturing division of Innocoll, Inc. and produces clinicalsupply or commercial product to its marketing partners and to Innocoll’s twoother divisions, Innocoll Technologies and Innocoll Pharmaceuticals.Using proprietary manufacturing processes, Syntacoll converts raw collagenmaterial and incorporates medicinal compounds yielding finished pharmaceuticalproduct in the form of a sponge or membrane. This system formsthe basis of Innocoll’s lead collagen-based technology, CollaRx. The spongeor membrane product format is a unique way to locally deliver a wide varietyof medicinal compounds and is fully biodegradable and resorbable. Thesponge and the membrane formats can be implanted at the time of surgeryor applied topically to a chronic, acute or traumatic wound. Delivering druglocally to the site of action has a number of benefits, including the safe deliveryof higher doses than could be achieved through systemic routes andavoidance of systemic side effects.Contact:Dr. Alexandra DietrichDonaustr. 24D-93342 Saal/DonauPhone: +49 (0) 9441 68600Fax: +49 (0) 9441 686030E-Mail: info@syntacoll.deInternet: www.innocoll.deTemmler Werke GmbHPHARMA & CHEMICAL INDUSTRYThe Temmler Group, with its 7 production sites in Europe, is one of the largestproviders of contract services in the pharmaceutical environment.Temmler has a wide experience in formulation development of finishedsolid, semi-solid and liquid dosage forms, in manufacture, packaging,blinding, distribution and return handling of clinical trial supplies, in theoptimization of established manufacturing processes as well as in thecontract manufacture of medicinal products with marketing authorization,supplemented by Quality Control and Analytical services.Temmler offers services from stand-alone processes according to customerspecifications, to strategic services comprising the entire supply chain.Contact:Dr. Claudio LorckWeihenstephaner Str. 28D-81673 MünchenPhone: +49 (0) 89 427299-01Fax: +49 (0) 89 427299-1000E-Mail: info@temmler.euInternet: www.temmler.deTHERMOSOME GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSKeywords: Drug Delivery, Liposomes, OncologyFounded in 2010, Thermosome is a biotech company developing new drugdelivery systems for therapeutic and diagnostic agents based on temperature-sensitiveliposomes.The company is using a novel liposome technology based on synthetic phosphatidyloligoglycerolsthat provides liposomes with prolonged circulation halflifeand ultra-fast release properties. Drug release shall be triggered by theapplication of energy from an exogenous or endogenous device (e.g. regionalhyperthermia, high intensity focused ultrasound) to the patient receiving thetreatment. Thermosome will make use of its platform technology in order to notonly enhance the efficacy of the drug but also to reduce systemic side effects.THERMOSOME GmbHContact:PD Dr. Lars LindnerSilberblattstr. 18aD-81377 MünchenPhone: +49 (0) 179 5368303Fax: +49 (0) 89 71668340E-Mail: info@thermosome.comInternet: www.thermosome.com113